πŸ‡ΊπŸ‡Έ FDA
Patent

US 11739074

Ras inhibitors

granted A61PA61P35/00

Quick answer

US patent 11739074 (Ras inhibitors) held by Revolution Medicines, Inc. expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Revolution Medicines, Inc.
Grant date
Tue Aug 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61P, A61P35/00